Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
ETON: 45% | Eton Pharmaceuticals Q2 EPS $0.18 Beats $(0.09) Estimate, Sales $12.00M Beat $6.51M Estimate